Effect of Puberty on the Pharmacodynamic and Pharmacokinetic Properties of Insulin Pump Therapy in Youth With Type 1 Diabetes
- 1 January 2008
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 31 (1), 44-46
- https://doi.org/10.2337/dc07-0737
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Pharmacokinetics, Prandial Glucose Control, and Safety of Insulin Glulisine in Children and Adolescents With Type 1 DiabetesDiabetes Care, 2005
- Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects.Diabetes Care, 1999
- Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart.Diabetes Care, 1998
- [Lys(B28), Pro(B29)]-Human Insulin: A Rapidly Absorbed Analogue of Human InsulinDiabetes, 1994
- [Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulinDiabetes, 1994
- Insulin Resistance of Puberty: a Defect Restricted to Peripheral Glucose Metabolism*Journal of Clinical Endocrinology & Metabolism, 1991
- Puberty decreases insulin sensitivityThe Journal of Pediatrics, 1987
- Impaired Insulin Action in PubertyNew England Journal of Medicine, 1986
- Glucose clamp technique: a method for quantifying insulin secretion and resistance.American Journal of Physiology-Endocrinology and Metabolism, 1979